Millipore Sigma Vibrant Logo

324630 EHNA, Hydrochloride - CAS 51350-19-7 - Calbiochem

The racemic mixture of a cell-permeable adenine derivative that acts as a PDE II-selective phosphodiesterase inhibitor and adenosine deaminase.

MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.

同义词: erythro-9-(2-Hydroxy-3-nonyl)adenine, HCl

Primary Target: PDE 2
View Products on Sigmaaldrich.com
324630
查看价格及供货情况

概述

Replacement Information

重要规格表

CAS #Empirical Formula
51350-19-7C₁₄H₂₃N₅O · HCl

价格及供货情况

产品目录编号 库存情况包装 数量 / 包装 价格 数量
324630-10MGCN
正在查询供货情况......
—
目前缺货 目前缺货
有货 
停产
少量现货
供货情况有待确认
    其余：另行通知
      其余：另行通知
      另行通知
      联系客户服务
      Contact Customer Service

      		 塑胶安瓿;塑胶针药瓶 10 mg
      正在检索价格......
      无法检索价格。
      最小订购数量为倍数
      Maximum Quantity is
      以订单确认为准 更多信息
      您节约了 ()。
       
      —
      Request Pricing
      		 —
      Description
      OverviewThe racemic mixture of a cell-permeable adenine derivative that acts as a PDE II-selective phosphodiesterase inhibitor (IC50 = 0.8 and 2 µM against human and procine PDE II, respectively) and adenosine deaminase (Ki = 4 nM), while exhibiting little or much reduced potency toward PDE I/II/IV isozymes (IC50 >100 µM) of both human and porcine species. EHNA at 10 µM concentration is also reported to effectively and reversibly block the differentiation and maintain the pluripotency of hES (human embryonic stem) cell line SA121 in feeder-free cultures without exogenously added FGF for up to 30 passages in a manner independent of its known ADA and PDE inhibitory activities.
      Catalogue Number324630
      Brand Family Calbiochem®
      Synonymserythro-9-(2-Hydroxy-3-nonyl)adenine, HCl
      References
      ReferencesBurton, P., et al. 2010. Biochem. J. in press.
      Lorbar, M., et al. 1999. J. Mol. Cell. Cardiol. 31, 401.
      Verde, I., et al. 1999. Br. J. Pharmacol. 127, 65.
      Reynolds, A.J., et al. 1996. Brain Res. 798, 67.
      Mery, P.F., et al. 1995. Mol. Pharmacol. 48, 121.
      Podzuweit, T., et al. 1995. Cell. Signal. 7, 733.
      Bessodes, M., et al. 1982. Biochem. Pharmacol. 31, 879.
      Bouchard, P., et al. 1981. Proc. Natl. Acad. Sci. USA 78, 1033.
      Product Information
      CAS number51350-19-7
      ATP CompetitiveN
      FormWhite solid
      Hill FormulaC₁₄H₂₃N₅O · HCl
      Chemical formulaC₁₄H₂₃N₅O · HCl
      Hygroscopic Hygroscopic
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetPDE 2
      Primary Target IC<sub>50</sub>0.8 and 2 µM against human and procine PDE II, respectively
      Primary Target K<sub>i</sub>4 nM against adenosine deaminase
      Purity≥97% by HPLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Hygroscopic Hygroscopic
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze at -20°C. Stock solutions are stable for up to 6 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      产品目录编号 GTIN
      324630-10MGCN 04055977196733

      Documentation

      EHNA, Hydrochloride - CAS 51350-19-7 - Calbiochem MSDS

      职位

      物料安全数据表 (MSDS) 

      EHNA, Hydrochloride - CAS 51350-19-7 - Calbiochem 分析证书

      标题批号
      324630

      参考

      参考信息概述
      Burton, P., et al. 2010. Biochem. J. in press.
      Lorbar, M., et al. 1999. J. Mol. Cell. Cardiol. 31, 401.
      Verde, I., et al. 1999. Br. J. Pharmacol. 127, 65.
      Reynolds, A.J., et al. 1996. Brain Res. 798, 67.
      Mery, P.F., et al. 1995. Mol. Pharmacol. 48, 121.
      Podzuweit, T., et al. 1995. Cell. Signal. 7, 733.
      Bessodes, M., et al. 1982. Biochem. Pharmacol. 31, 879.
      Bouchard, P., et al. 1981. Proc. Natl. Acad. Sci. USA 78, 1033.
      数据表

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision09-February-2012 RFH
      Synonymserythro-9-(2-Hydroxy-3-nonyl)adenine, HCl
      DescriptionThe racemic mixture of a cell-permeable adenine derivative that acts as a PDE II-selective phosphodiesterase inhibitor (IC50 = 0.8 and 2 µM against human and procine PDE II, respectively) and adenosine deaminase (Ki = 4 nM), while exhibiting little or much reduced potency toward PDE I/II/IV isozymes (IC50 >100 µM) of both human and porcine species. EHNA at 10 µM concentration is also reported to effectively and reversibly block the differentiation and maintain the pluripotency of hES (human embryonic stem) cell line SA121 in feeder-free cultures without exogenously added FGF for up to 30 passages in a manner independent of its known ADA and PDE inhibitory activities.
      FormWhite solid
      CAS number51350-19-7
      Chemical formulaC₁₄H₂₃N₅O · HCl
      Structure formulaStructure formula
      Purity≥97% by HPLC
      SolubilityH₂O (25 mg/ml)
      Storage +2°C to +8°C
      Hygroscopic
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze at -20°C. Stock solutions are stable for up to 6 months at -20°C.
      Toxicity Standard Handling
      ReferencesBurton, P., et al. 2010. Biochem. J. in press.
      Lorbar, M., et al. 1999. J. Mol. Cell. Cardiol. 31, 401.
      Verde, I., et al. 1999. Br. J. Pharmacol. 127, 65.
      Reynolds, A.J., et al. 1996. Brain Res. 798, 67.
      Mery, P.F., et al. 1995. Mol. Pharmacol. 48, 121.
      Podzuweit, T., et al. 1995. Cell. Signal. 7, 733.
      Bessodes, M., et al. 1982. Biochem. Pharmacol. 31, 879.
      Bouchard, P., et al. 1981. Proc. Natl. Acad. Sci. USA 78, 1033.